Encouraged by an FDA approval, companies design cancer drugs to work in any solid tumor
Nation hopes reforms will yield more and better drugs
How Anne Wojcicki took the start-up firm from the brink of failure to scientific preeminence.
For big pharma, the perfect patient is wealthy, permanently ill and a daily pill-popper. Will medicine ever recover?